
Sign up to save your podcasts
Or


A surgeon in burns reconstruction, Matt Klein swapped the operating room for the equally high-pressure environment of drug development. In this episode of Pathfinders in Biopharma, he sets out the vision for the company he now leads, PTC Therapeutics – a pioneer in the field of RNA therapies, now powering towards profitability with treatment candidates for a host of rare diseases.
By RBC Capital Markets5
1212 ratings
A surgeon in burns reconstruction, Matt Klein swapped the operating room for the equally high-pressure environment of drug development. In this episode of Pathfinders in Biopharma, he sets out the vision for the company he now leads, PTC Therapeutics – a pioneer in the field of RNA therapies, now powering towards profitability with treatment candidates for a host of rare diseases.

3,228 Listeners

1,728 Listeners

974 Listeners

1,976 Listeners

1,657 Listeners

1,095 Listeners

126 Listeners

338 Listeners

1,046 Listeners

1,317 Listeners

6,128 Listeners

34 Listeners

41 Listeners

21 Listeners

10 Listeners

0 Listeners

84 Listeners

18 Listeners

15 Listeners

3 Listeners